Evidence map›Paper›PMID 36686675›Full record

ArticleFrontiers in pharmacology2022

Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats.

Haigang Li, Yi Zhou, Luanfeng Liao, Hongyi Tan, Yejun Li, Zibo Li, Bilan Zhou, Meihua Bao, Binsheng He

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Antimicrobial Susceptibility Profiles of CommensalAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The effects of fermentedFrontiers in veterinary science · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Effects ofFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haigang LiHunan key laboratory of the research and development of novel pharmaceutical preparations, Changsha Medical University, Changsha, China.
Yi ZhouHunan key laboratory of the research and development of novel pharmaceutical preparations, Changsha Medical University, Changsha, China.
Luanfeng LiaoDepartment of Pharmacy, Changsha Medical University, Changsha, China.
Hongyi TanCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yejun LiCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zibo LiDepartment of medical laboratory, Changsha Medical University, Changsha, China.
Bilan ZhouDepartment of Pharmacy, Changsha Health Vocational College, Changsha, China.
Meihua BaoHunan key laboratory of the research and development of novel pharmaceutical preparations, Changsha Medical University, Changsha, China.
Binsheng HeHunan key laboratory of the research and development of novel pharmaceutical preparations, Changsha Medical University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chuanxionggut microbiotaMCAO (middle cerebral artery occlusion)pharmacokineticsUPLC-MS/MSwarfarin

Identifiers

PMID36686675
PMCPMC9849362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.